Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Derek Chauvin, the ex-Minneapolis police officer convicted of second-degree murder in the killing of George Floyd, has filed an appeal requesting a new trial. Chauvin submitted the filing last month ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

Get ready for an epic showdown as two boxing legends, Mike Tyson and Floyd Mayweather Jr., gear up to step into the ring for an exhibition match in Spring 2026. Floyd Mayweather last fought ...

Kirk made the statement in reference to Floyd's alleged criminal history and the circumstances surrounding his death. Kirk's exact words were: "I am also going to offer some context and some nuance ...

The boxing world was hit with a big announcement on Thursday night when former heavyweight champion Mike Tyson and former multi-division champion Floyd Mayweather said they agreed to a bout to be held ...